Discovery of Potent and Highly Selective Thienopyridine Janus Kinase 2 Inhibitors

Laurie B. Schenkel(Amgen (United States)), Stephanie Geuns-Meyer(Amgen (United States)), Holly L. Deak(Amgen (United States)), Philip R. Olivieri(Amgen (United States)), Bin Wu(China Astronaut Research and Training Center), Violeta Yu(Amgen (United States)), Jin Tang(Central South University), Shen‐Wu Wang(Capital Medical University), Mary C. Wells(Amgen (United States)), Qian Wan(First Affiliated Hospital of Xiamen University), Renee Emkey(Amgen (United States)), Hakan Günaydin(Amgen (United States)), Josie Lee(Amgen (United States)), Robert D. Loberg(Amgen (United States)), Jeanne Pistillo(Amgen (United States)), Alan C. Cheng, Yan Gu(Amgen (United States)), Huiling Wang(Wuhan University), Xin Huang(Amgen (United States)), Liqin Liu(Xinjiang Agricultural University), Elizabeth M. Doherty(CHDI Foundation), Joseph L. Kim(Blueprint Medicines (United States))
Journal of Medicinal Chemistry
November 16, 2011
Cited by 43


Related Papers